ATE314390T1 - Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren - Google Patents
Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimierenInfo
- Publication number
- ATE314390T1 ATE314390T1 AT98945924T AT98945924T ATE314390T1 AT E314390 T1 ATE314390 T1 AT E314390T1 AT 98945924 T AT98945924 T AT 98945924T AT 98945924 T AT98945924 T AT 98945924T AT E314390 T1 ATE314390 T1 AT E314390T1
- Authority
- AT
- Austria
- Prior art keywords
- genetically manipulated
- manipulated cells
- bone morphogenesis
- proteins
- express bone
- Prior art date
Links
- 230000034127 bone morphogenesis Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 abstract 3
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 abstract 3
- 229940112869 bone morphogenetic protein Drugs 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000003305 autocrine Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003076 paracrine Effects 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5798997P | 1997-09-05 | 1997-09-05 | |
| US09/148,234 US20020102728A1 (en) | 1997-09-05 | 1998-09-04 | Genetically engineered cells which express bone morphogenetic proteins |
| PCT/US1998/018603 WO1999011664A1 (en) | 1997-09-05 | 1998-09-04 | Genetically engineered cells which express bone morphogenetic proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE314390T1 true ATE314390T1 (de) | 2006-01-15 |
Family
ID=22013954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98945924T ATE314390T1 (de) | 1997-09-05 | 1998-09-04 | Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20020102728A1 (de) |
| EP (1) | EP1007559B1 (de) |
| JP (1) | JP2001514026A (de) |
| AT (1) | ATE314390T1 (de) |
| AU (1) | AU752556B2 (de) |
| CA (1) | CA2301882A1 (de) |
| DE (1) | DE69832989T2 (de) |
| DK (1) | DK1007559T3 (de) |
| ES (1) | ES2255180T3 (de) |
| MX (1) | MXPA00002318A (de) |
| PT (1) | PT1007559E (de) |
| WO (1) | WO1999011664A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030039695A1 (en) * | 2001-08-10 | 2003-02-27 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Collagen carrier of therapeutic genetic material, and method |
| US9034315B2 (en) | 1997-10-10 | 2015-05-19 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Cell-charged multi-layer collagen membrane |
| US20050186283A1 (en) | 1997-10-10 | 2005-08-25 | Ed. Geistlich Soehne Ag Fuer Chemistrie Industrie | Collagen carrier of therapeutic genetic material, and method |
| US8858981B2 (en) | 1997-10-10 | 2014-10-14 | Ed. Geistlich Soehne Fuer Chemistrie Industrie | Bone healing material comprising matrix carrying bone-forming cells |
| JP2003505205A (ja) * | 1999-07-28 | 2003-02-12 | リジェネレーション テクノロジーズ インク． | 核酸送達ビヒクルとしての軟骨マトリクス又は骨マトリクス |
| US6939540B1 (en) * | 2000-07-31 | 2005-09-06 | Cornell Research Foundation, Inc. | Method of enhancing bone density |
| WO2003013588A1 (fr) * | 2001-08-08 | 2003-02-20 | Kaken Pharmaceutical Co., Ltd. | Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire |
| JP4097544B2 (ja) * | 2003-02-27 | 2008-06-11 | 独立行政法人理化学研究所 | 人工リンパ節 |
| AU2004255245B2 (en) * | 2003-07-09 | 2009-10-22 | Warsaw Orthopedic, Inc. | Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| US20050272678A1 (en) * | 2004-02-11 | 2005-12-08 | Bodine Peter Van N | BMP-6 estrogen responsive element and methods of use thereof |
| US7531355B2 (en) * | 2005-07-29 | 2009-05-12 | The Regents Of The University Of California | Methods and compositions for smooth muscle reconstruction |
| US20120263692A1 (en) * | 2009-11-16 | 2012-10-18 | Bertone Alicia L | Engineered Xenogeneic Cells for Repair of Biological Tissue |
| AU2016333996B2 (en) | 2015-10-05 | 2020-05-28 | Salk Institute For Biological Studies | Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| US5763416A (en) * | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
| WO1996039431A1 (en) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Bone morphogenic protein-10 |
-
1998
- 1998-09-04 AU AU93062/98A patent/AU752556B2/en not_active Ceased
- 1998-09-04 ES ES98945924T patent/ES2255180T3/es not_active Expired - Lifetime
- 1998-09-04 WO PCT/US1998/018603 patent/WO1999011664A1/en active IP Right Grant
- 1998-09-04 PT PT98945924T patent/PT1007559E/pt unknown
- 1998-09-04 EP EP98945924A patent/EP1007559B1/de not_active Expired - Lifetime
- 1998-09-04 CA CA002301882A patent/CA2301882A1/en not_active Abandoned
- 1998-09-04 DK DK98945924T patent/DK1007559T3/da active
- 1998-09-04 US US09/148,234 patent/US20020102728A1/en not_active Abandoned
- 1998-09-04 MX MXPA00002318A patent/MXPA00002318A/es not_active IP Right Cessation
- 1998-09-04 JP JP2000508702A patent/JP2001514026A/ja not_active Withdrawn
- 1998-09-04 DE DE69832989T patent/DE69832989T2/de not_active Expired - Lifetime
- 1998-09-04 AT AT98945924T patent/ATE314390T1/de active
-
2011
- 2011-01-19 US US13/008,955 patent/US20110111505A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1007559E (pt) | 2006-05-31 |
| US20110111505A1 (en) | 2011-05-12 |
| US20020102728A1 (en) | 2002-08-01 |
| EP1007559B1 (de) | 2005-12-28 |
| MXPA00002318A (es) | 2006-02-22 |
| DE69832989D1 (de) | 2006-02-02 |
| AU752556B2 (en) | 2002-09-19 |
| DK1007559T3 (da) | 2006-05-08 |
| EP1007559A1 (de) | 2000-06-14 |
| AU9306298A (en) | 1999-03-22 |
| ES2255180T3 (es) | 2006-06-16 |
| DE69832989T2 (de) | 2006-08-24 |
| WO1999011664A1 (en) | 1999-03-11 |
| CA2301882A1 (en) | 1999-03-11 |
| JP2001514026A (ja) | 2001-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE314390T1 (de) | Genetisch manipulierte zellen die knochenmorphogeneseproteinen exprimieren | |
| ATE540973T1 (de) | Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung | |
| ATE404583T1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| IL150566A0 (en) | Nucleic acids and polypeptides and nogo-receptor proteins | |
| WO1999035262A3 (en) | Apoptosis inducing molecule ii | |
| TR199802421T2 (xx) | Doku yenilenmesini d�zenleyen maddeler. | |
| WO1999040197A3 (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
| WO2002014358A3 (en) | Novel secreted proteins and their uses | |
| ATE391778T1 (de) | Mutanten des vaskulären, endothelzellen- spezifischen wachstumsfaktors c (vegf-c) und deren verwendungen | |
| DE69819167D1 (de) | Modifizierter, das dorsalgewebe beeinflussender faktor | |
| NZ510367A (en) | Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector | |
| WO1998049300A3 (en) | Truncated vegf-related proteins | |
| ATE291633T1 (de) | Rekombinante adenovirale vektoren, die chimäre fiberproteine exprimieren, für die zellspezifische infektion und genomische integration | |
| WO2001098491A3 (en) | Osteolevin gene polymorphisms | |
| WO1997026322A3 (en) | Methods and compositions for inhibiting hexokinase | |
| WO2002050111A3 (en) | Isolated laminin 10 | |
| FI971896A0 (fi) | BMP-tyyppi II-reseptoria koodaava cDNA | |
| HK1002284A1 (en) | Novel implant and novel vector for the treatment of acquired diseases | |
| BR9812138A (pt) | Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta | |
| WO2000061774A3 (en) | Bone morphogenic proteins | |
| UA72875C2 (uk) | БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ | |
| DE69831223D1 (de) | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 | |
| WO2002014369A3 (en) | Human kininogen d5 domain polypeptides and their use | |
| WO1998031805A3 (en) | Human zinc binding proteins | |
| WO2001000662A3 (en) | The use of human fgh-8 polypeptides as neurotrophic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1007559 Country of ref document: EP |